Cardiopulmonary and Neurologic Dysfunctions in Fibrodysplasia Ossificans Progressiva

• Main Authors: Fatima Khan, Xiaobing Yu, Edward C. Hsiao
• Format: Article
• Language: English
• Published: MDPI AG 2021-02-01
• Series: Biomedicines
• Subjects: fibrodysplasia ossificans progressiva; FOP; cardiac conduction abnormalities; ACVR1; neuropathic pain; cardiac dysfunction
• Online Access: https://www.mdpi.com/2227-9059/9/2/155

Fibrodysplasia Ossificans Progressiva (FOP) is an ultra-rare but debilitating disorder characterized by spontaneous, progressive, and irreversible heterotopic ossifications (HO) at extraskeletal sites. FOP is caused by gain-of-function mutations in the Activin receptor Ia/Activin-like kinase 2 gene (<i>Acvr1/Alk2</i>), with increased receptor sensitivity to bone morphogenetic proteins (BMPs) and a neoceptor response to Activin A. There is extensive literature on the skeletal phenotypes in FOP, but a much more limited understanding of non-skeletal manifestations of this disease. Emerging evidence reveals important cardiopulmonary and neurologic dysfunctions in FOP including thoracic insufficiency syndrome, pulmonary hypertension, conduction abnormalities, neuropathic pain, and demyelination of the central nervous system (CNS). Here, we review the recent research and discuss unanswered questions regarding the cardiopulmonary and neurologic phenotypes in FOP.